About the Ocugen, Inc. The company's shares closed last Wednesday at $7. Ocugen (OCGN) said Wednesday it is moving forward with plans to file an emergency use authorization application for the Covaxin COVID-19 vaccine with the--Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating 10:30AM ET 5/10/2021 MT Newswires. As a result, OCGN is trading at a discount of 36. HC Wainwright is very positive about OCGN and gave it a "Buy" rating on June 11, 2021. In the past week, OCGN stock shed -2. 00 and a median price target of $0. This suggests that the stock has a possible downside of 4. Ocgn price target. 220 Followers, 171 Following. 00 while the price target rests at a high of $10. Ocugen closes US$100 million direct offering at premium. Cantor Fitzgerald raised the price target for the Ocugen Inc. The investigation focuses on whether the Company issued. These are the details. 50 in a research report sent to investors on Thursday, The Fly reports. A high-level overview of Ocugen, Inc. Ocugen (NASDAQ:OCGN) Price Target and Consensus Rating 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. June 10, 2021 Ocugen to pursue a BLA path in the US for its COVID-19 vaccine candidate. 88 in pre-market trading. Though the vaccine […]. 40pp Target Price N/A Return Potential 0. Bollinger Bands are 67. 6% premium to OCGN's closing price of US$9. Up-to-date news stories for Ocugen Inc (OCGN). Data & News supplied by www. - June 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ocugen, Inc. - 6/3/2021 7:30:00 AM: Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:10:59 AM Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/27/2021 4:09:36 PM Ocugen on track to submit U. 68% and +27. 28: Current Quarter's Estimate-0. NEW YORK, Jun 12, 2021--Bragar Eagel & Squire, P. (OCGN) stock has rocketed from penny stock status in recent months as the company, a biopharmaceutical firm developing gene therapies for eye diseases, has turned its attention to developing a Covid-19 vaccine. 578 USD for 2026 June 13, Saturday with technical analysis. The offer price was at a 7. On the charts, Ocugen stock is far from. Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 2:17:44 PM Hot Stocks: OCGN needs another trial, Reddit chatter, earnings for FCEL and GME Seeking Alpha - 6/10/2021 9:17:54 AM: Ocugen shares plunge 38% after likely needing additional trial for Covaxin Seeking Alpha - 6/10/2021 8:06:20 AM: Ocugen Inc. (OCGN) stock had plunged by-11. 25, implying an increase of 15. For more insight on analysts targets of OCGN, see our OCGN price target page. 89bio, Inc. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page. 56, close to its 52-week low of $0. 00 and a median price target of $0. Ask Warren HQ @askwarrenbuffet This is a parody account! Wise words plus my own spoof satirical stock market predictions that have no basis in fact, never believe them, do your due diligence!. The high price target for OCGN is $11. 07:48AM EDT 10 Biggest Price Target Changes For Friday Benzinga 07:02AM EDT Roth Capital Downgrades Ocugen to Neutral, Lowers Price Target to $6 Benzinga 06:11AM EDT HC Wainwright & Co. 00 in a research report released on Friday morning, The Fly reports. 23, with the Price to Sales ratio for OCGN stock in the period of the last 12 months amounting to 40996. EPS/Price Divergence 1m -69. Riley FBR initiated coverage with a Buy rating and a price target of $29. Stocktwits is the largest social network for finance. They currently have a buy rating on the stock. 17% (time horizon: 1 day) and results in a price target of $6. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OCGN stock is a recommendation set at 2. (NASDAQ: OCGN) from $10 to $6. OCGN is wide open to the upside. OCUGEN INC OCGN STOCK CHART ANALYSIS | OCUGEN INC OCGN STOCK CHART ANALYSIS | OCUGEN INC OCGN STOCK CHART ANALYSISJoin me on twitter for stocks I am watching. Ocugen, Inc. 87 Cboe Real-Time Last Sale as of 2:37PM ET 6/10/21 Cboe Real-Time Quotes --Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains. The rating was released on May 07, 2021. The projected low price target is $4. Their forecasts range from $4. The 4 analysts offering 12-month price forecasts for Ocugen Inc have a median target of 12. News Corp is a global, diversified media and information services company focused on creating and distributing. 29 and the 52 weeks low is $0. Refer to the full report for the price target, fundamental analysis, and rating. * Indexes up: Dow 0. Ocugen, Inc. The previous price target was $33. Ocugen (NASDAQ:OCGN) had its target price cut by Chardan Capital from $8. The shares of Ocugen Inc (NASDAQ: OCGN) have received a $10 price target by Roth Capital. The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $13 based on the research report published on February 09th of the current year 2021. OCGN Ocugen — Stock Price and Discussion | Stocktwits. Ocugen Stock Forecast, OCGN stock price prediction. PriceTargets. , a nationally recognized shareholder rights law firm, is investigating potential claims against Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Mean Target Price. Shares in Ocugen Inc are currently priced at $8. The latest Ocugen, Inc (OCGN) stock price, news and insider information. We are up to 970 followers despite not giving out a lot of alerts, a fact that we think is indicative of a successful, diligent and prudent stock picking history. OCGN has an average analyst recommendation of Buy. Serious News for Serious Traders! Try StreetInsider. 70) By Chardan Capital The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital. Ocugen, Inc. 55 in the near term, which indicates a potential 42. 00, also on the back of analyst coverage. 00 and the low price target for OCGN is $4. 5 based on the average […]. The high price target for OCGN is $11. 7 million compared to $12. The share price climbed from a low of just $0. The average analyst rating is 4. It is currently valued at $8. In recent trading, shares of Ocugen Inc (OCGN) have crossed above the average analyst 12-month target price of $10. (NASDAQ: OCGN) on behalf of Ocugen stockholders. 73 on Wednesday. OCGN updated stock price target summary. The latest Ocugen, Inc (OCGN) stock price, news and insider information. Ocugen (NASDAQ:OCGN) had its price target dropped by stock analysts at Chardan Capital from $13. 50 in the report published on February 04th of the current year. OCGN also received an analyst downgrade on Tuesday as Chardan analyst Keay Nakae warned of the euphoria surrounding Ocugen, and lowered the price target to $13. 760$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). 1 million reported last year. View today's stock price, news and analysis for Ocugen Inc. >Historical Ratings The table shows the mean historical analyst recommendation for the current period, along with the previous 1, 2, and 3 periods. Shares of Novan (NOVN) has gone up in anticipation of today's investor meeting. Analysts covering Ocugen Inc currently have a consensus Earnings Per Share (EPS) forecast of 1. (OCGN) stock. 29% from the last price of $6. 00 in a report published on Wednesday, The Fly reports. During this period of time, the stock fell as low as $6. The share price climbed from a low of just $0. caldooninvestment May 24. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen - Ascending Triangle 🔺5. [ Stock price forecast for the next 10days ] Get detailed stock price forecast information including price target, investing positions, trend forecast pretiming: OCGN. Roth Capital cut the price target on Ocugen, Inc. Dow Jones, a News Corp company About WSJ. 18 and is up $0. 70 with a high of $1. 19% from the company’s previous close. The firm currently has a “neutral” rating on the stock. 00 (from $40. This suggests that the stock has a possible downside of 2. Ocugen shares rose 2. They currently have a neutral rating on the stock. Ocugen Reaches Analyst Target Price Thursday, December 24, 8:32 AM ET, by Market News Video Staff. Its Simple. 4 Wall Street analysts have issued 12-month price objectives for Ocugen's stock. 00 in a note issued to investors on Monday, The Fly reports. (NASDAQ: OCGN) on behalf of Ocugen stockholders. Roth Capital raised their price target on shares […]. Shares of OCGN opened at $8. The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. The average price target represents a 24. The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). Wainwright gave a rating of “Buy” to OCGN, setting the target price at $4. 9 million compared to $1. The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $13 based on the research report published on February 09th of the current year 2021. Ocugen shares rose 2. 00 in the next twelve months. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Rooms Shows Rankings Earnings Calendar Shop. As a result, the OCGN stock price has seen a 2,200% gain over the past year of trading. (OCGN) called "Why Ocugen Is Set To Soar Again Tomorrow". By accessing this page, you agree to the following. The share price climbed from a low of just $0. (OCGN) stock. OCGN: Get the latest Ocugen stock price and detailed information including OCGN news, historical charts and realtime prices. 70 with a high of $1. 28: Current Quarter's Estimate-0. Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 2:17:44 PM Hot Stocks: OCGN needs another trial, Reddit chatter, earnings for FCEL and GME Seeking Alpha - 6/10/2021 9:17:54 AM: Ocugen shares plunge 38% after likely needing additional trial for Covaxin Seeking Alpha - 6/10/2021 8:06:20 AM: Ocugen Inc. 30, close to its 52-week low of $0. Price target in 14 days: 6. These are the details. OCGN stock closed at $2. For investors who are trying to double their money there are some obvious paths: Penny stocks and cryptocurrency immediately come to mind. OCGN also received an analyst downgrade on Tuesday as Chardan analyst Keay Nakae warned of the euphoria surrounding Ocugen, and lowered the price target to $13. The deal prompted Roth Capital analyst ZegbehJallah to raise the firm’s price target on Ocugen from $1 to $8. 75% from current levels. Monday, May 10, 2021. DoorDash Expands Footprint to Japan; Street Sees 23% Upside. (NASDAQ: OCGN) to $4. 55 in the near term, which indicates a potential 42. In-depth view of key statistics and finances for OCUGEN, INC. 00 price target. 29% from the last price of $6. 17%) 05/07/21 Cantor Fitzgerald Ocugen downgraded to Neutral from Overweight at Cantor Fitzgerald Kluska lowered the firm's price target to $11, down from $15, citing increasing near-term expenses and lowering near-term probability-adjusted COVAXIN sales in light of a delayed EUA application filing. (GOVX) in OCGN And GOVX Are Two Cheap COVID Vaccine Plays. The median estimate represents a +23. -Stop-Loss: $7. 00 and the low price target for OCGN is $4. 567 for the next financial year. About the Ocugen, Inc. Ocugen Inc. 88, suggesting a possible upside of 28. Ocgn price target. Ocugen Inc OCGN:NASDAQ. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target of $10 by Roth Capital. It is currently valued at $8. POWR Ratings Reflect Bleak Prospects. 00 and a low forecast of $4. The company’s shares closed last Friday at $0. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Ocgn price target. News Corp is a global, diversified media and information services company focused on creating and distributing. Novan (NOVN) to reach price target of $1. Analysts covering Ocugen Inc currently have a consensus Earnings Per Share (EPS) forecast of 1. Description: Ocugen Inc is a clinical-stage biopharmaceutical company. (NASDAQ: OCGN) had its price target lowered by analysts at Chardan Capital from $13. OCGN : Ocugen stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year). OCGN also received an analyst downgrade on Tuesday as Chardan analyst Keay Nakae warned of the euphoria surrounding Ocugen, and lowered the price target to $13. 00 and the low price target for OCGN … P. 19% at the previous closing. 04: Year Ago Earnings-0. Cantor Fitzgerald has the highest price target set, predicting OCGN will reach $11. OCGN has been the subject of a number of other research reports. Chardan Capital’s target price points to a potential downside of 19. Ocugen, Inc. 00 with a high estimate of $ 0. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. 17%) 05/07/21 Cantor Fitzgerald Ocugen downgraded to Neutral from Overweight at Cantor Fitzgerald Kluska lowered the firm's price target to $11, down from $15, citing increasing near-term expenses and lowering near-term probability-adjusted COVAXIN sales in light of a delayed EUA application filing. , a nationally recognized shareholder rights law firm, is investigating potential claims against Ocugen, Inc. 5, and a low price target of $10. is set at 1. Our target price on GOVX is based on 15% of VXRT's market cap of $656 million. Past 12 Months 12 Months Forecast -$1 $2. Shares of Ocugen (NASDAQ:OCGN) fell on Tuesday after an analyst sounded a note of caution to investors. Ocugen (NASDAQ:OCGN) had its price objective lowered by stock analysts at Chardan Capital from $8. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. EST, the biopharmaceutical company's stock price was down more than 15%. caldooninvestment May 24. Rooms Shows Rankings Earnings Calendar Shop. , a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. OCGN - Ocugen, Inc. (NASDAQ: OCGN) Citi upgraded from Neutral to Buy with a price target of $42. OCGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Support Quality Journalism. The firm has a market capitalization of $1. On average, Wall Street analysts predict that. OCUGEN INC OCGN STOCK CHART ANALYSIS | OCUGEN INC OCGN STOCK CHART ANALYSIS | OCUGEN INC OCGN STOCK CHART ANALYSISJoin me on twitter for stocks I am watching. ~ Broker 👉 portfolio manager ⏩ Technical analysis Pro. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and. The shares of Ocugen Inc (NASDAQ: OCGN) have received a $10 price target by Roth Capital. Analyst Target. The best long-term & short-term Ocugen share price prognosis for 2021, 2022. stock news by MarketWatch. NEW YORK, Jun 12, 2021--Bragar Eagel & Squire, P. OCGN stock price saw a surge of 7. They currently have a neutral rating on the stock. However, it’s important to keep in mind that the vast majority of analyst coverage on the stock is outdated. # of Recs. Ocugen, Inc. The projected low price target is $4. (NASDAQ: OCGN) to $4. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. 70) By Chardan Capital By Amit Chowdhry February 9, 2021 The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital. , a nationally recognized shareholder rights law firm, is investigating potential claims against Ocugen, Inc. 00 in a note issued to investors on Monday, The Fly reports. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. 00 in a report issued on Monday morning, The Fly reports. 25, which implies an increase of 17. Zacks Investment Research cut Ocugen from a hold rating to a sell rating in a report on Wednesday, May 26th. PriceTargets. As such, OCGN has been trading 34. And so with OCGN crossing above that average target price of $12. OCGN stock previously closed at $10. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target increase from $9 to $10 by Roth Capital. PriceTargets. 567 for the next financial year. According to. However, Chardan Capital downgraded the stock to “Neutral” from “Buy” based on the recent stock price surge. 00 (from $1. 50/share, investors in OCGN have been given a good signal to spend fresh time assessing the company and deciding for themselves: is. 88 in pre-market trading. Ocugen (NASDAQ:OCGN) Price Target and Consensus Rating 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. As far as vaccine plays go, Ocugen (OCGN) remains an intriguing speculative pick today. 00 in a research report released on Friday morning, The Fly reports. (GOVX) in OCGN And GOVX Are Two Cheap COVID Vaccine Plays. The narrow width of the bands suggests low volatility as compared to OCGN's normal range. Thus, we can expect to see OCGN rise to $8. Their average twelve-month price target is $7. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Ocugen Inc and even bonds. This is a good deal lower than my previous price target of $12. 90, changing hands for $2. HC Wainwright is very positive about OCGN and gave it a "Buy" rating on June 11, 2021. (OCGN) stock had plunged by-11. Ocgn price target. Ocugen Inc. High Target Price. The company has many of the traits speculators seek in a moon-shot target. They now have a "neutral" rating on the stock. And so with OCGN crossing above that average target price of $12. ("Ocugen" or "the Company") (NASDAQ: OCGN) for violations of the securities laws. Ocugen (NASDAQ:OCGN) had its target price cut by HC Wainwright from $12. The shares of Ocugen Inc (NASDAQ: OCGN) have received a $10 price target by Roth Capital. OCGN price target $15 EOY Thoughts? After a massive beat down and consolidation, OCGN just popped up today on news that it chose a manufacturer to their product which aims to aid combating against COVID variants which are emerging in India and Brazil at massive amounts. - June 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ocugen, Inc. Ocugen, Inc( NASDAQ: OCGN) Ocugen, Inc. The price target was changed from $12. Refer to the full report for the price target, fundamental analysis, and rating. The narrow width of the bands suggests low volatility as compared to OCGN's normal range. Get (NASDAQ | OCGN Ocugen, Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report. OCGN Ocugen $2. View the real-time CTRM price chart on Robinhood and decide if you want to buy or sell commission-free. Pivot points are used to identify intraday support, resistance and target levels. 65% above the. Analysts' Take According to TipRanks' analyst rating consensus, OCGN stock comes in as a Moderate Buy. The average price target represents a 24. ABR vs Zacks Rank. Ocugen's share price could stay at $10. ("Ocugen" or "the Company") (NASDAQ: OCGN) for violations of the securities laws. 04: Year Ago Earnings-0. Ocugen stock has a median target price of $1, which is a premium of 24 percent over its closing prices on Dec. (NASDAQ: OCGN) to $4. 28: Current Quarter's Estimate-0. 1% narrower than normal. 00 while slashing his price target for Avis Budget Group from $11. The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). Our target price on GOVX is based on 15% of VXRT's market cap of $656 million. Stock Advisor list. (NASDAQ: OCGN) on behalf of Ocugen stockholders. 47% from the low figure of 52 weeks. (OCGN) called "Why Ocugen Is Set To Soar Again Tomorrow". Ocugen stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. OCGN is currently trading at $6. 75% within the next two weeks. (NASDAQ: OCGN) Citi upgraded from Neutral to Buy with a price target of $42. The stock skyrocketed around 200% last week after the biopharmaceutical firm struck a deal to develop a promising coronavirus vaccine candidate to be used in the United States. In recent trading, shares of Ocugen Inc (OCGN) have crossed above the average analyst 12-month target price of $10. (NASDAQ: OCGN) had its price target raised by analysts at Roth Capital from $1. Ocugen (NASDAQ:OCGN) had its target price cut by Chardan Capital from $8. Ocgn price target. Ask Warren HQ @askwarrenbuffet This is a parody account! Wise words plus my own spoof satirical stock market predictions that have no basis in fact, never believe them, do your due diligence!. And there's also the risky world of options to consider as well. 1 million reported last year. 03: Current Year's Estimate-0. Several other analysts have also recently issued reports on OCGN. Shalu Saraf Jun 09, 2021. 30, close to its 52-week low of $0. 88, predicting that the stock has a possible upside of 24. OCGN also received an analyst downgrade on Tuesday as Chardan analyst Keay Nakae warned of the euphoria surrounding Ocugen, and lowered the price target to $13. And so with OCGN crossing above that average target price of $12. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. 6% premium to OCGN's closing price of US$9. The shares of Ocugen Inc (NASDAQ: OCGN) have received a $10 price target by Roth Capital. Ocugen Inc. Comtech reported revenue of $139. Ocugen (NASDAQ:OCGN) had its target price raised by Cantor Fitzgerald from $1. 04: Year Ago Earnings-0. 13% from the 50-Day Moving Average. com - 1 - H. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Ocugen (NASDAQ:OCGN) Inc on Monday, setting a price target of $12, which is approximately 34. 67% from the company's previous close. The analyst firm set a price target for 11. The offer price was at a 7. Shares of Ocugen (NASDAQ:OCGN) Ramakanth is very bullish about Ocugen. OCGN updated stock price target summary. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis. 75% within the next two weeks. caldooninvestment May 24. 5 based on the average […]. Cantor Fitzgerald has the highest price target set, predicting OCGN will reach $11. These are the details. OCGN Ocugen $2. Market News. Last week we reiterated our bullish calls on Ocugen, Inc. 50 -- a 60% premium to Ocugen's closing price on Wednesday. Ocugen stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. The analyst firm set a price target for 11. The Average True Range (ATR) for Ocugen Inc. 50/share, investors in OCGN have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $12. Ocugen shares rose 2. 2% from the $135. HC Wainwright's target price indicates a potential upside of 52. On average, Wall Street analysts predict that. OCGN Ocugen $9. The price movement of OCGN has been highly volatile as the company closes in on its EUA submission to the US FDA. Ocgn price target. Ocugen (NASDAQ:OCGN) Price Target and Consensus Rating 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. Our investigation concerns whether Ocugen has violated the federal securities laws and/or engaged in other unlawful business practices. Analysts at Cantor Fitzgerald initiated coverage of the stock with an Overweight rating and a price target of $58. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $347. 65% from the high point of 52 weeks and flying high of 4576. 4 Wall Street analysts have set twelve-month price targets for Ocugen in the last year. Ocugen Inc. (NASDAQ:OCGN) stock from “an Overweight” to “a Neutral”. The new note on the price target was released on February 04, 2021, representing the official price target for Ocugen Inc. OCGN Stock Price: $13 Target (Up From $0. Shares of OCGN opened at $8. The brokerage currently has a neutral rating on the stock. At that level they are trading at 11. 00 and a low forecast of $4. OCGN Stock Price: $13 Target (Up From $0. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 5% during intraday trading this morning. As of 2021 June 13, Sunday current price of OCGN stock is 7. News Corp is a global, diversified media and information services company focused on creating and distributing. io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. 5% discount to current levels, leaving plenty of room for upgrades in the near future. 60 and keep rising, we can see a major rise to $15. caldooninvestment May 24. Analysts on Wall Street suggest a consensus price target of $10. In depth view into OCGN (Ocugen) stock including the latest price, news, dividend history, earnings information and financials. Other analysts have also […]. OCGN price target $15 EOY Thoughts? After a massive beat down and consolidation, OCGN just popped up today on news that it chose a manufacturer to their product which aims to aid combating against COVID variants which are emerging in India and Brazil at massive amounts. 38 in the next twelve months. Their average twelve-month price target is $7. 00 price target. A market cap of $98 million would lead to a stock price of over $15. Experts target price for OCGN is 12$. Ocugen (NASDAQ: OCGN) is the biotech stock everyone's been talking about these past few months. (OCGN) More Company Research Source: MarketBeat. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher. Institutions purchased OCGN at 10$/share. Ideas & Insights. 17%) 05/07/21 Cantor Fitzgerald Ocugen downgraded to Neutral from Overweight at Cantor Fitzgerald Kluska lowered the firm's price target to $11, down from $15, citing increasing near-term expenses and lowering near-term probability-adjusted COVAXIN sales in light of a delayed EUA application filing. The price target was changed from $12. , a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. 73 billion, a price-to-earnings ratio of -28. Based on analysts offering 12 month price targets for OCGN in the last 3 months. Refer to the full report for the price target, fundamental analysis, and rating. US)盤前漲逾16%,公司就新冠疫苗COVAXIN建立生産夥伴關系. 29 and the 52 weeks low is $0. 美股異動 | Ocugen(OCGN. 07:48AM EDT 10 Biggest Price Target Changes For Friday Benzinga 07:02AM EDT Roth Capital Downgrades Ocugen to Neutral, Lowers Price Target to $6 Benzinga 06:11AM EDT HC Wainwright & Co. What's more, OCGN's 12-month consensus price target of $5. 19% from the company's previous close. 00 and a median price target of $0. Ocgn price target. Any comparable with a viable Covid-19 vaccine is trading at far greater prices. (NASDAQ: OCGN) on behalf of Ocugen stockholders. Specifically, Bharat Biotech had announced the Phase 3 clinical trial results for its coronavirus vaccine candidate Covaxin. -Putting our target price to $15. Refer to the full report for the price target, fundamental analysis, and rating. The firm presently has a "buy" rating on the stock. Several other analysts have also recently issued reports on OCGN. AgEagle Aerial Systems Stock Forecast, UAVS stock price prediction. Announces Michael Shine as Senior Vice President, Commercial. Their average twelve-month price target is $0. 50 in a research report sent to investors on Thursday, The Fly reports. Roth Capital cut the price target on Ocugen, Inc. Institutions purchased OCGN at 10$/share. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Last Price. HC Wainwright reiterated a hold rating on shares of Ocugen in a research note on Monday, November 9th. 00 while slashing his price target for Avis Budget Group from $11. HC Wainwright's target price indicates a potential upside of 52. The further forecasts for the OCUGEN INC share price are: 0. 29% from the last price of $6. com, Nakae is a 4-star analyst with an average return of 11. 17 in mid-2020 to start 2021 at $3. PriceTargets. They currently have a buy rating on the stock. In February, OCGN made a contractual agreement with Bharat Biotech to produce the Covaxin Covid-19 vaccine, which showed minimal side effects and had an 81% efficacy rate in phase 3 clinical trial in India soaring OCGN Stock price by 270%. 00, with the highest OCGN stock price forecast at $13. Latest Analyst Research & Price Targets for Ocugen Inc (OCGN-Q). As a result, OCGN is trading at a discount of 36. Ocgn price target Ocgn price target. ("Ocugen" or "the Company") (NASDAQ: OCGN) for violations of the securities laws. 60 and keep rising, we can see a major rise to $15. NEW YORK, Jun 12, 2021--Bragar Eagel & Squire, P. 13% off the targeted high while a plunge would see the stock lose 34. 00 in a report released on Wednesday morning, The Fly reports. 00, with the highest OCGN stock price forecast at $13. Ocugen (NASDAQ:OCGN) had its price objective trimmed by HC Wainwright from $12. OCGN has an Overall Score of 67. Ocugen (OCGN) stock price prediction is 25. Thus, we can expect to see OCGN rise to $8. The 4 analysts offering 12-month price forecasts for Ocugen Inc have a median target of 12. Trending now. Ocugen (NASDAQ: OCGN) is the biotech stock everyone's been talking about these past few months. The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital from $0. Ocugen (NASDAQ:OCGN) had its price objective reduced by investment analysts at HC Wainwright from $12. The average price target is $7. As of May 04. If OCGN manages to keep the nose above the level 7. Support Quality Journalism. 38, suggesting a possible downside of 13. Ocgn price target. 00 in a report issued on Monday morning, The Fly reports. 3Q21 Results. Ocugen (NASDAQ:OCGN) had its target price cut by HC Wainwright from $12. Jallah had cited Ocugen's vaccine partner. 04: Year Ago Earnings-0. Ocgn price target. 00) while maintaining a Overweight rating. 28: Current Quarter's Estimate-0. 93 billion for OCGN would lead to a stock price of over $20. At that level they are trading at 11. 00 (from $1. Wainwright, on the other hand, stated in their research note that they expect to see OCGN reach a price target of $4. US)盤前漲逾16%,公司就新冠疫苗COVAXIN建立生産夥伴關系. Based on analysts offering 12 month price targets for OCGN in the last 3 months. 01% to the stock's current value. 5 based on the average […]. Stocktwits is the largest social network for finance. 00 while slashing his price target for Avis Budget Group from $11. 50 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking. According to. (OCGN) called "Why Ocugen Is Set To Soar Again Tomorrow". Price is very aggressively channelling higher. The best long-term & short-term Ocugen share price prognosis for 2021, 2022. Ocugen, Inc. PriceTargets. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. The average price target is $7. We are up to 970 followers despite not giving out a lot of alerts, a fact that we think is indicative of a successful, diligent and prudent stock picking history. Target Price: Price: 10. Our target price on GOVX is based on 15% of VXRT's market cap of $656 million. Cantor Fitzgerald analyst Kristen Kluska raised the firm's price target on Ocugen to $15 from $4 and keeps an Overweight rating on the shares after the company's partner, Bharat Biotech, released preliminary Phase 3 data from the ongoing trial for the Covaxin vaccine for COVID-19. For the readers interested in the stock health of Ocugen Inc. 02% from the company's current price. At that time, OCGN had indicated that it intends to bring Covaxin to the US market. Get (NASDAQ | OCGN Ocugen, Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report. I think if OCGN close today below the line marked with the orange star it can move all way down to $6 area ,but stay alert if that zone gets. Roth Capital cut the price target on Ocugen, Inc. Based on analysts offering 12 month price targets for OCGN in the last 3 months. 2% and a 47. OCGN Ocugen $2. Based on 4 Wall Street analysts offering 12 month price targets for Ocugen in the last 3 months. 2 out of 4 analysts covering the stock have rated it a Buy, while 2 have maintained a Hold recommendation on Ocugen Inc. They currently have an overweight rating on the stock. Chardan Capital lowered their price target on shares of Ocugen from $8. 73 billion, a price-to-earnings ratio of -28. Bollinger Bands are 67. 32965 USD for 2022 June 13, Monday; and 188. Ocugen shares rose 2. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Ocugen today and set a price target of $10. com keeps track of all major brokerages’ stock ratings and recommendations, including Goldman Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch. By providing you with our Ocugen stock price prediction you may potentially be in a better position to plan out your trades ahead of time. Ocgn price target Ocgn price target. >Historical Ratings The table shows the mean historical analyst recommendation for the current period, along with the previous 1, 2, and 3 periods. The shares of Ocugen Inc (NASDAQ: OCGN) have received a price target of $10 by Roth Capital. The 12-month mean consensus price target for the company's shares has been set at $9. The rating was released on May 07, 2021. 04: Year Ago Earnings-0. Low Target Price. 00 and the low price target for OCGN is $4. The analyst commented, "We reiterate. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Castor Maritime against related stocks people have also bought like ZOM, SNDL, NAKD, and NAK. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases. The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 5% during intraday trading this morning. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis. 00 in the next twelve months. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Ocugen Inc and even bonds. OCGN Stock Price: $13 Target (Up From $0. The positive price action comes after the company announced it is is partnering with Jubilant HollisterStier to manufacture its Covid-19 vaccine candidate Covaxin™ for use in the U. 1% narrower than normal. AgEagle Aerial Systems Stock Forecast, UAVS stock price prediction. Ocugen Inc. These are the details. 50 -- a 60% premium to Ocugen's closing price on Wednesday. 01% from its likely low. 13% from the 50-Day Moving Average. Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. 70) By Chardan Capital The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital. The average target price for the stock is $4. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. 16 and a beta of 4. Ocugen (NASDAQ:OCGN) Price Target and Consensus Rating 4 Wall Street analysts have issued ratings and price targets for Ocugen in the last 12 months. -Vaccine-associated spike protein in blood circulation could explain myriad reported adverse events from COVID. Synopsys Snaps Up Code Dx, Expands Application Security Portfolio. Join me while I discuss what happened and what I believe will happ. OCGN has closed below upper band by 36. The average target price for the stock is $4. Based on analysts offering 12 month price targets for OCGN in the last 3 months. Ocugen Inc OCGN:NASDAQ. Investors are responding to news by Ocugen partner Bharat Biotech. 29% from the last price of $6. On the charts, Ocugen stock is far from. 47% from the low figure of 52 weeks. 00 and the low price target for OCGN … P. 70) By Chardan Capital By Amit Chowdhry February 9, 2021 The stock price of Ocugen Inc (NASDAQ: OCGN) has received a price target increase by Chardan Capital. 02/04/2021 Ocugen, Inc. Ocugen stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Last Price. 70 with a high of $1. 00 while slashing his price target for Avis Budget Group from $11. (OCGN) estimates and. Ocgn price target. The brokerage currently has a neutral rating on the stock. 73 on Wednesday. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. (NASDAQ: OCGN) on behalf of Ocugen stockholders. Today I break down a popular penny stock currently (OCGN). Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. The company has a debt-to-equity ratio. 50 and as high as $16. Ocugen (OCGN) stock price prediction is 25. 00 and a median price target of $0. While the situation remains very fluid, the. Comtech reported revenue of $139. (OCGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. This is a good deal lower than my previous price target of $12. Ocugen (NASDAQ:OCGN) had its target price trimmed by Chardan Capital from $13. Currently, four analysts cover Ocugen, according to Market Beat. Ocgn price target. 50 in a research report sent to investors on Thursday, The Fly reports. Data & News supplied by www. Its Simple. (OCGN) More Company Research Source: MarketBeat. Latest Analyst Research & Price Targets for Ocugen Inc (OCGN-Q). 2 million shares of common stock outstanding as of March 31, 2021. Los Angeles, California-- (Newsfile Corp. 32965 USD for 2022 June 13, Monday; and 188. In that case, then, we find that the current price level is -63. The price movement of OCGN has been highly volatile as the company closes in on its EUA submission to the US FDA. In recent trading, shares of Ocugen Inc (OCGN) have crossed above the average analyst 12-month target price of $10. (NASDAQ: OCGN) had its price target lowered by analysts at Chardan Capital from $13. 70 with a high of $1. Get (NASDAQ | OCGN Ocugen, Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report. The stock price of Ocugen Inc (NASDAQ: OCGN) is trading at over 35% pre-market. The latest price target for Ocugen ( NASDAQ: OCGN) was reported by Cantor Fitzgerald on 2021-05-07. (OCGN) stock has rocketed from penny stock status in recent months as the company, a biopharmaceutical firm developing gene therapies for eye diseases, has turned its attention to developing a Covid-19 vaccine. Their forecasts range from $4. The rating was released on May 07, 2021. - 6/3/2021 7:30:00 AM: Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/1/2021 6:10:59 AM Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/27/2021 4:09:36 PM Ocugen on track to submit U.